Kun Yu Selected Research

cucurbitacin IIa

1/2020

Synthesis of cucurbitacin IIa derivatives with apoptosis-inducing capabilities in human cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kun Yu Research Topics

Disease

38	Neoplasms (Cancer) 06/2022 - 05/2004
12	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2004
11	Wounds and Injuries (Trauma) 10/2022 - 01/2016
7	Neoplasm Metastasis (Metastasis) 04/2022 - 06/2008
7	Inflammation (Inflammations) 02/2022 - 01/2012
5	Hypoxia (Hypoxemia) 06/2022 - 12/2017
5	Carcinoma (Carcinomatosis) 01/2020 - 08/2004
4	Myocardial Infarction 05/2022 - 01/2019
4	Thyroid Neoplasms (Thyroid Cancer) 04/2022 - 08/2017
4	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2022 - 01/2019
4	Hemorrhage 12/2021 - 12/2015
4	Infections 05/2021 - 12/2006
4	Stomach Neoplasms (Stomach Cancer) 12/2020 - 06/2008
4	Acute Kidney Injury (Acute Renal Failure) 01/2019 - 06/2011
4	Reperfusion Injury 01/2019 - 02/2011
4	Colitis 01/2019 - 01/2018
3	Myocarditis (Carditis) 01/2022 - 08/2017
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 07/2008
3	Bacterial Infections (Bacterial Infection) 05/2021 - 10/2018
3	Necrosis 01/2019 - 01/2018
3	Lung Neoplasms (Lung Cancer) 11/2018 - 05/2007
3	Hemolysis 02/2018 - 06/2011
2	Atherosclerosis 02/2022 - 01/2022
2	Papillary Thyroid Cancer 01/2022 - 01/2016
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 10/2021
2	Septic Shock (Toxic Shock Syndrome) 01/2022 - 02/2019
2	Constipation 01/2022 - 01/2018
2	Ischemia 08/2021 - 06/2011
2	Infarction (Infarctions) 08/2021 - 01/2019
2	Infertility (Sterility) 01/2021 - 12/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2014
2	Endocrine System Diseases (Endocrine Diseases) 01/2021 - 01/2019
2	Rheumatoid Arthritis 01/2021 - 01/2021
2	Lymphatic Metastasis 01/2020 - 01/2019
2	B-Cell Lymphoma (Lymphoma, B Cell) 04/2018 - 08/2017
2	Liver Diseases (Liver Disease) 02/2018 - 01/2014
2	Hyperglycemia 12/2017 - 12/2010
2	Hyperlipidemias (Hyperlipidemia) 12/2017 - 10/2016
2	Colonic Neoplasms (Colon Cancer) 04/2017 - 01/2015
2	Obesity 10/2016 - 01/2014
2	Cardiogenic Shock 06/2011 - 12/2009

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 10/2021 - 04/2008
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2008
7	Estrogen ReceptorsIBA 01/2021 - 05/2004
6	Messenger RNA (mRNA)IBA 01/2022 - 04/2008
6	Biological ProductsIBA 01/2022 - 06/2006
5	CytokinesIBA 01/2021 - 01/2012
4	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2014
4	Therapeutic UsesIBA 10/2021 - 12/2017
4	Caspase 3 (Caspase-3)IBA 08/2021 - 01/2014
4	ChitosanIBA 12/2018 - 01/2016
4	Small Interfering RNA (siRNA)IBA 08/2017 - 07/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022 - 07/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022 - 01/2021
3	Estrogens (Estrogen)FDA Link 01/2022 - 01/2019
3	Hemostatics (Antihemorrhagics)IBA 12/2021 - 12/2015
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2021 - 01/2012
3	Interleukin-6 (Interleukin 6)IBA 04/2021 - 05/2018
3	Long Noncoding RNAIBA 01/2021 - 01/2019
3	Phenobarbital (Luminal)FDA Link 12/2019 - 08/2004
3	GoldIBA 12/2018 - 11/2017
3	6-formylindolo(3,2-b)carbazoleIBA 10/2018 - 01/2018
2	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 05/2022 - 08/2017
2	Mitochondrial Permeability Transition PoreIBA 05/2022 - 05/2011
2	Superoxide DismutaseIBA 05/2022 - 01/2019
2	Malondialdehyde (Propanedial)IBA 05/2022 - 01/2019
2	oxidized low density lipoproteinIBA 02/2022 - 01/2022
2	Sirolimus (Rapamycin)FDA Link 01/2022 - 07/2008
2	ResveratrolIBA 01/2022 - 10/2021
2	HydrogelsIBA 11/2021 - 12/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2021 - 10/2018
2	Selective Estrogen Receptor Modulators (SERM)IBA 01/2021 - 09/2006
2	Tamoxifen FDA LinkGeneric 01/2021 - 09/2006
2	LipidsIBA 01/2020 - 10/2016
2	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2019 - 01/2012
2	Hormones (Hormone)IBA 12/2019 - 01/2019
2	CXC ChemokinesIBA 11/2019 - 04/2017
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2014
2	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 12/2018 - 10/2018
2	GelatinIBA 10/2018 - 01/2016
2	SodiumIBA 10/2018 - 05/2018
2	Dextrans (Dextran)FDA Link 10/2018 - 05/2018
2	LigandsIBA 05/2018 - 07/2015
2	Janus KinasesIBA 04/2018 - 08/2014
2	SilverIBA 03/2018 - 11/2017
2	jatrorrhizineIBA 12/2017 - 10/2016
2	SolutionsIBA 09/2017 - 01/2017
2	Sericins (Sericin)IBA 09/2017 - 01/2017
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2017 - 01/2017
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2017 - 01/2009
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 01/2015
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2011 - 02/2011
2	BuffersIBA 05/2011 - 02/2011

Therapy/Procedure

15	Therapeutics 05/2022 - 07/2008
5	Drug Therapy (Chemotherapy) 10/2021 - 07/2008
5	Extracorporeal Membrane Oxygenation 08/2016 - 12/2009
2	Operative Surgical Procedures 01/2022 - 12/2021
2	Ligation 01/2022 - 08/2021
2	Critical Care (Surgical Intensive Care) 01/2022 - 02/2019
2	Thyroidectomy 10/2020 - 01/2019